Functions of antibodies
DN Forthal - Microbiology spectrum, 2014 - Am Soc Microbiol
Antibodies can impact pathogens in the presence or in the absence of effector cells or
effector molecules such as complement, and experiments can often sort out with precision …
effector molecules such as complement, and experiments can often sort out with precision …
Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies
H Lu, T Hong, Y Jiang, M Whiteway, S Zhang - Advanced Drug Delivery …, 2023 - Elsevier
Candidiasis is an infection caused by fungi from a Candida species, most commonly
Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on …
Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on …
An insight into the antifungal pipeline: selected new molecules and beyond
L Ostrosky-Zeichner, A Casadevall… - Nature reviews Drug …, 2010 - nature.com
Invasive fungal infections are increasing in incidence and are associated with substantial
mortality. Improved diagnostics and the availability of new antifungals have revolutionized …
mortality. Improved diagnostics and the availability of new antifungals have revolutionized …
Treatment of Cryptococcal meningitis: how have we got here and where are we going?
NTT Ngan, B Flower, JN Day - Drugs, 2022 - Springer
Cryptococcal meningitis is a devastating brain infection cause by encapsulated yeasts of the
Cryptococcus genus. Exposure, through inhalation, is likely universal by adulthood, but …
Cryptococcus genus. Exposure, through inhalation, is likely universal by adulthood, but …
HIV-associated cryptococcal meningitis
JN Jarvis, TS Harrison - Aids, 2007 - journals.lww.com
While the incidence of cryptococccal meningitis in the developed world has declined with
widespread, early antiretroviral therapy (ART), cryptococcal disease remains a major …
widespread, early antiretroviral therapy (ART), cryptococcal disease remains a major …
A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in …
J Pachl, P Svoboda, F Jacobs… - Clinical Infectious …, 2006 - academic.oup.com
Abstract Background. Mycograb (Neu Tec Pharma) is a human recombinant monoclonal
antibody against heat shock protein 90 that, in laboratory studies, was revealed to have …
antibody against heat shock protein 90 that, in laboratory studies, was revealed to have …
Immunotherapies against human bacterial and fungal infectious diseases: A review
Nations' ongoing struggles with a number of novel and reemerging infectious diseases,
including the ongoing global health issue, the SARS-Co-V2 (severe acute respiratory …
including the ongoing global health issue, the SARS-Co-V2 (severe acute respiratory …
New approaches for cryptococcosis treatment
Cryptococcosis is an important opportunistic infection and a leading cause of meningitis in
patients with HIV infection. The antifungal pharmacological treatment is limited to …
patients with HIV infection. The antifungal pharmacological treatment is limited to …
An overview of the management of the most important invasive fungal infections in patients with blood malignancies
A Shariati, A Moradabadi, Z Chegini… - Infection and drug …, 2020 - Taylor & Francis
In patients with hematologic malignancies due to immune system disorders, especially
persistent febrile neutropenia, invasive fungal infections (IFI) occur with high mortality …
persistent febrile neutropenia, invasive fungal infections (IFI) occur with high mortality …
Cryptococcal therapies and drug targets: the old, the new and the promising
C Coelho, A Casadevall - Cellular microbiology, 2016 - Wiley Online Library
Half a century after the introduction of Amphotericin B the management of cryptococcosis
remains unsatisfactory. The disease, caused primarily by the two fungal species …
remains unsatisfactory. The disease, caused primarily by the two fungal species …